Kestra Advisory Services’s Citius Pharmaceuticals CTXR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-3,701
| Closed | -$46.3K | – | 2667 |
|
|
2024
Q3 | $46.3K | Sell |
3,701
-43
| -1% | -$538 | ﹤0.01% | 2492 |
|
|
2024
Q2 | $54.6K | Buy |
3,744
+508
| +16% | +$7.41K | ﹤0.01% | 2551 |
|
|
2024
Q1 | $72.6K | Buy |
3,236
+339
| +12% | +$7.6K | ﹤0.01% | 2384 |
|
|
2023
Q4 | $54.8K | Sell |
2,897
-769
| -21% | -$14.5K | ﹤0.01% | 2213 |
|
|
2023
Q3 | $62.7K | Buy |
3,666
+40
| +1% | +$684 | ﹤0.01% | 2045 |
|
|
2023
Q2 | $109K | Sell |
3,626
-51
| -1% | -$1.53K | ﹤0.01% | 1990 |
|
|
2023
Q1 | $108K | Sell |
3,677
-72
| -2% | -$2.11K | ﹤0.01% | 1948 |
|
|
2022
Q4 | $74K | Buy |
3,749
+222
| +6% | +$4.38K | ﹤0.01% | 2164 |
|
|
2022
Q3 | $107K | Buy |
3,527
+683
| +24% | +$20.7K | ﹤0.01% | 1976 |
|
|
2022
Q2 | $65K | Buy |
2,844
+1,239
| +77% | +$28.3K | ﹤0.01% | 2022 |
|
|
2022
Q1 | $72K | Sell |
1,605
-124
| -7% | -$5.56K | ﹤0.01% | 1946 |
|
|
2021
Q4 | $67K | Buy |
1,729
+91
| +6% | +$3.53K | ﹤0.01% | 1964 |
|
|
2021
Q3 | $83K | Buy |
+1,638
| New | +$83K | ﹤0.01% | 2068 |
|